Oxiracetam Offers Neuroprotection by Reducing Amyloid β-Induced Microglial Activation and Inflammation in Alzheimer's Disease

Background: Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation in the brain, which triggers the activation of microglia; in turn, microglia release neuroinflammatory factors capable of damaging neurons. Thus, a therapeutic approach targeting this sustained microglia-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Heng, Jia, Longfei, Jia, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380077/
https://www.ncbi.nlm.nih.gov/pubmed/32765394
http://dx.doi.org/10.3389/fneur.2020.00623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380077/
https://www.ncbi.nlm.nih.gov/pubmed/32765394
http://dx.doi.org/10.3389/fneur.2020.00623

Ejemplares similares